Actionnariat et activité des initiés pour MaxCyte, Inc. (MXCT): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.18 |
| Capitalisation | $126M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $11.7M | $25.3M | $11.2M | $15.2M | $18.8M | $47.8M | $11.1M | $46.5M | $27.9M | $20.1M |
| Placements à Court Terme | 0 | 0 | $3.2M | $1.5M | $16.0M | $207.3M | $216.3M | $121.8M | $126.6M | $83.0M |
| Créances | $2.4M | $3.2M | $4.9M | $3.2M | $5.2M | $6.9M | $11.2M | $5.8M | $4.7M | $3.5M |
| Stocks | $1.3M | $1.3M | $2.2M | $3.7M | $4.3M | $5.2M | $8.6M | $12.2M | $8.9M | $7.5M |
| Actifs Courants | $15.8M | $30.6M | $22.4M | $24.5M | $45.3M | $270.4M | $252.3M | $190.2M | $171.7M | $118.4M |
| Immobilisations Corporelles | $281500 | $847600 | $1.8M | $5.5M | $6.5M | $13.4M | $33.6M | $34.8M | $30.5M | $28.5M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $650000 |
| Actifs Totaux | $16.1M | $31.4M | $24.3M | $30.0M | $51.8M | $284.1M | $286.7M | $268.3M | $239.5M | $202.5M |
| Dettes Fournisseurs | $3.2M | $4.3M | $1.0M | $2.1M | $890200 | $1.8M | $292000 | $743000 | $1.4M | $1.4M |
| Dette à Court Terme | 0 | $850900 | 0 | 0 | 0 | 0 | 0 | 0 | $864000 | $1.5M |
| Passifs Courants | $5.7M | $7.2M | $6.6M | $9.3M | $11.6M | $15.6M | $15.4M | $17.9M | $15.8M | $14.3M |
| Dette à Long Terme | $5.0M | $4.2M | $5.1M | $4.9M | $4.9M | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $11.0M | $11.8M | $12.0M | $16.4M | $18.6M | $21.2M | $32.7M | $36.1M | $33.2M | $31.0M |
| Réserves | -$51.7M | -$61.6M | -$70.5M | -$83.4M | -$95.2M | -$114.3M | -$137.9M | -$175.8M | -$216.9M | -$261.5M |
| Capitaux Propres | $5.1M | $19.6M | $12.3M | $13.6M | $33.2M | $262.9M | $254.0M | $232.2M | $206.3M | $171.5M |
| Dette Totale | $5.0M | $5.0M | $5.1M | $7.2M | $7.0M | $5.7M | $16.1M | $18.7M | $18.0M | $17.9M |
| Dette Nette | -$6.7M | -$20.3M | -$9.4M | -$9.5M | -$27.8M | -$249.4M | -$211.2M | -$149.5M | -$136.4M | -$85.1M |
| Fonds de Roulement | $10.1M | $23.3M | $15.9M | $15.1M | $33.6M | $254.8M | $236.8M | $172.3M | $155.9M | $104.1M |
Santé financière
| Dette / Capitaux propres | 0.11 |
| Ratio de liquidité | 12.26 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 1.43 |
Rentabilité
| Rentabilité des capitaux propres | -21.01% |
| Rentabilité du capital investi | -19.66% |
| Rentabilité des actifs | -19.30% |
| Marge brute | 79.43% |
| Marge opérationnelle | -111.63% |
| Marge nette | -114.77% |
Entreprises liées: ARMP · AVR · CATX · LNSR · NNOX · OWLT · PRE
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de MXCT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions